When designing semaglutide, a realistic concern was if it would be possible to stabilize a GLP-1 analog against systemic clearance to achieve plasma levels sufficient to control blood glucose following OW dosing
Individuelle Lsungen fr zukunftsfhige Entwicklungen Unser Unternehmen Becker Personal + Perspektiven untersttzt Unternehmen seit fast 20 Jahren durch Personalberatung in der Region Berlin, Potsdam und dem Land Brandenburg
Small, Frequent Meals Are Your Friend Lighten the Load : Instead of big meals that can overload your digestive system, go for smaller portions throughout the day
TRIUMPH-1 has closed: The main obesity trial (NCT05929066) completed enrollment in April 2026
The goal should be improved metabolic function, better body composition, and a lower-risk physiologic state
Also, a systematic review and meta-analysis found no significant difference in DR outcomes, including DR, macular edema, vitreous abnormality, requirement for eye-related surgery, and blindness, between SGLT2i and placebo users (risk ratio, 0.98